Here’s why a slowdown might mean more IPOs in tech, but fewer in biotech

The economic slowdown in the past couple of months could lead to long-term changes for Boston’s innovation industry, giving some tech startups the chance to stay independent, while pushing biotech firms toward acquisitions.